GRK 2381 "cGMP: From Bedside to Bench"


Prof. Dr. Robert Feil
(Speaker GRK 2381)

robert.feilspam prevention@uni-tuebingen.de

In this Research Training Group  ("Graduiertenkolleg" 2381, GRK 2381) entitled "cGMP: From Bedside to Bench", doctoral researchers will investigate the second messenger cyclic guanosine monophosphate (cGMP). cGMP is responsible for the transmission of signals in cells, and many drugs for the treatment of cardiovascular diseases target this signaling pathway. The latest findings suggest that cGMP-modulating drugs can be used even more widely. This will be investigated by the junior scientists of the GRK 2381.

Further information about the GRK 2381 



GRK 2381 at TÜFFF

"Hörsaalzentrum Morgenstelle" on 24 May 2019

Read more


9th International Conference on cGMP

cGMP: Generators, Effectors and Therapeutic Implications

Read more


New Research Training Group "cGMP: From Bedside to Bench"

The newly approved GRK 2381 investigates new therapeutic options for established cGMP-modulating...

Read more

Speaker of the Research Training Group


Prof. Dr. Robert Feil 
Interfakultäres Institut für Biochemie (IFIB)
Hoppe-Seyler-Str. 4
72076 Tübingen
robert.feilspam prevention@uni-tuebingen.de 


Vice Speaker

Prof. Dr. Robert Lukowski 
Experimentelle Pharmakologie
Institut für Pharmazie
Auf der Morgenstelle 8
72076 Tübingen
robert.lukowskispam prevention@uni-tuebingen.de


Cooperation Partners